Clinical trial
Safety and Efficacy of Converting Maintenance Kidney and Liver Transplant…
NCT00150085 · Novartis, Industry · Terminated
Key facts
| NCT number | NCT00150085 |
|---|---|
| Title | Safety and Efficacy of Converting Maintenance Kidney and Liver Transplant Recipients With Abnormal Glucose Metabolism From Tacrolimus to Cyclosporine Micro-emulsion |
| Official title | A Prospective, Randomized, Open-label, Twenty-six Week Study of the Efficacy and Safety of Converting Kidney and Liver Transplant Recipients With Tacrolimus-associated Abnormal Glucose Metabolism to Cyclosporine Micro-emulsion With C2 Monitoring |
| Lead sponsor | Novartis, Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Tacrolimus-associated Abnormal Glucose Metabolism in Kidney and Liver Transplant Recipients |
| Intervention type | Drug |
| Interventions | cyclosporine micro-emulsion |
| Enrollment | 50 |
| Start date | Feb 1, 2004 |
| Primary completion | Oct 1, 2005 |
| Completion | Oct 1, 2005 |
| First posted | Sep 8, 2005 |
| Last update posted | Feb 18, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: